12 companies

Rubicon Research

Market Cap: ₹301.1b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

RUBICON

₹1,818.80

7D

1.1%

1Y

n/a

Acutaas Chemicals

Market Cap: ₹266.7b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ACUTAAS

₹3,257.80

7D

0.9%

1Y

130.5%

Sakar Healthcare

Market Cap: ₹20.1b

Research, develops, manufactures, and sells pharmaceutical products in India.

SAKAR

₹901.40

7D

3.5%

1Y

171.5%

Aether Industries

Market Cap: ₹219.6b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

AETHER

₹1,655.00

7D

0.9%

1Y

124.9%

CORONA Remedies

Market Cap: ₹128.6b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

CORONA

₹2,103.10

7D

-0.9%

1Y

n/a

Anthem Biosciences

Market Cap: ₹519.9b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

ANTHEM

₹923.05

7D

4.7%

1Y

10.4%

Senores Pharmaceuticals

Market Cap: ₹68.8b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

SENORES

₹1,494.70

7D

-3.6%

1Y

111.3%

Emcure Pharmaceuticals

Market Cap: ₹353.2b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

EMCURE

₹1,862.30

7D

-1.5%

1Y

26.8%

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹387.3b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

506943

₹2,412.25

7D

0%

1Y

40.5%

Laurus Labs

Market Cap: ₹1.0t

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

LAURUSLABS

₹1,887.00

7D

4.7%

1Y

117.2%

Supriya Lifescience

Market Cap: ₹62.9b

Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.

SUPRIYA

₹781.75

7D

-0.8%

1Y

18.8%

Shilpa Medicare

Market Cap: ₹168.2b

Offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.

530549

₹860.10

7D

6.5%

1Y

108.9%